Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours
André O. von Bueren(University of Geneva), Stefan Rutkowski(Universität Hamburg)
Cited by 46
Related Papers
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
|Acta Neuropathologica|2016|650
Subgroup-Specific Prognostic Implications of <i>TP53</i> Mutation in Medulloblastoma
|Journal of Clinical Oncology|2013|488
Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis
|Journal of Clinical Oncology|2016|206
Addressing gaps and enhancing experiences in support services for families of pediatric cancer survivors
|Pediatric Research|2024|18